Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-000750
Filing Date
2025-02-11
Accepted
2025-02-11 16:11:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3926
  Complete submission text file 0001950047-25-000750.txt   5441
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address
Levine Mark S. (Reporting) CIK: 0001617236 (see all company filings)

Type: 144

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Subject) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 144 | Act: 33 | File No.: 001-38906 | Film No.: 25609915
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)